In-vitro stability of peripheral nerve preparations: Relation to ischemic responses

Brain Research

Volumn 1337, Issue , 2010, Pages 1-7

  Stecker, Mark M ^a   Baylor, Kelly ^a   Stevenson, Matthew ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age; Hypoxia; Nerve action potential; Temperature; Wallerian degeneration

Indexed keywords

AGE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH TEMPERATURE; HYPOXIA; IN VITRO STUDY; LOW TEMPERATURE; MALE; NERVE POTENTIAL; NERVE TRANSECTION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; TEMPERATURE SENSITIVITY; THERMOSTABILITY; TISSUE PREPARATION;

ACTION POTENTIALS; AGE FACTORS; ANIMALS; ANOXIA; ELECTROPHYSIOLOGY; MALE; MODELS, NEUROLOGICAL; MYELIN SHEATH; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SYNAPTIC TRANSMISSION; TEMPERATURE; WALLERIAN DEGENERATION;

ANIMALIA; RATTUS; WALLERIA;

EID: 77952552350     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.04.015     Document Type: Article

References (20)

1. Alvarez S., Moldovan M., and Krarup C. Acute energy restriction triggers wallerian degeneration in mouse. Exp. Neurol. 212 (2008) 166-178
2. Araki T., Sasaki Y., and Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 (2004) 1010-1013
3. Astrup J., Symon L., Branston N.M., and Lassen N.A. Cortical evoked potential and extracellular K + and H + at critical levels of brain ischemia. Stroke. 8 (1977) 51-57
4. Chaudhry V., and Cornblath D.R. Wallerian degeneration in human nerves: serial electrophysiological studies. Muscle Nerve 15 (1992) 687-693
5. Gilliatt R.W., and Hjorth R.J. Nerve conduction during Wallerian degeneration in the balloon. J. Neurol. Neurosurg. Psychiatry 35 (1972) 335-341
6. Gillingwater T.H., Wishart T.M., Chen P.E., Haley J.E., Robertson K., MacDonald S.H., Middleton S., Wawrowski K., Shipston M.J., Melmed S., Wyllie D.J., Skehel P.A., Coleman M.P., and Ribchester R.R. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. Hum. Mol. Genet. 15 (2006) 625-635
7. Hansson S. The association between nerve conduction velocity and the compound action potential amplitude during ischemic blocking. Electromyogr. Clin. Neurophysiol. 39 (1999) 113-122
8. Hofteig J.H., Vo P.N., Yates A.J., and Leon K.S. Peripheral nerve phospholipid composition: development in normal nerve and age-dependent changes in wallerian degenerated nerve. J. Neurochem. 39 (1982) 401-408
9. Laser H., Conforti L., Morreale G., Mack T.G., Heyer M., Haley J.E., Wishart T.M., Beirowski B., Walker S.A., Haase G., Celik A., Adalbert R., Wagner D., Grumme D., Ribchester R.R., Plomann M., and Coleman M.P. The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Mol. Biol. Cell 17 (2006) 1075-1084
10. Low P.A., Schmelzer J.D., and Ward K.K. The effect of age on energy metabolism and resistance to ischaemic conduction failure in rat peripheral nerve. J. Physiol. (Lond ). 374 (1986) 263-271
11. Low P.A., Schmelzer J.D., and Ward K.K. The effect of age on energy metabolism and resistance to ischaemic conduction failure in rat peripheral nerve. J. Physiol. 374 (1986) 263-271
12. Lunn E.R., Perry V.H., Brown M.C., Rosen H., and Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. NeuroSci. 1 (1989) 27-33
13. Mack T.G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D., Thomson D., Gillingwater T., Court F., Conforti L., Fernando F.S., Tarlton A., Andressen C., Addicks K., Magni G., Ribchester R.R., Perry V.H., and Coleman M.P. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4 (2001) 1199-1206
14. Maher P. Proteasome inhibitors prevent oxidative stress-induced nerve cell death by a novel mechanism. Biochem. Pharmacol. 75 (2008) 1994-2006
15. Stecker M.M., and Baylor K. Peripheral nerve at extreme low temperatures 1: effects of temperature on the action potential. Cryobiology 59 (2009) 1-11
16. Tsao J.W., Brown M.C., Carden M.J., McLean W.G., and Perry V.H. Loss of the compound action potential: an electrophysiological, biochemical and morphological study of early events in axonal degeneration in the C57BL/Ola mouse. Eur. J. NeuroSci. 6 (1994) 516-524
17. Tsao J.W., George E.B., and Griffin J.W. Temperature modulation reveals three distinct stages of Wallerian degeneration. J. Neurosci. 19 (1999) 4718-4726
18. Wang G.K. The long-term excitability of myelinated nerve fibres in the transected frog sciatic nerve. J. Physiol. 368 (1985) 309-321
19. Wishart T.M., Pemberton H.N., James S.R., McCabe C.J., and Gillingwater T.H. Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; wlds). Genome Biol. 9 (2008) R101
20. Yamada T., Muroga T., and Kimura J. Tourniquet-induced ischemia and somatosensory evoked potentials. Neurology 31 (1981) 1524-1529